Searching map area
Kunle Odunsi
? TBD
researcher
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Works 13
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
scientific article published in May 2015
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
scientific article published on 7 September 2016
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
scientific article published on April 2013
Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing.
scientific article
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
scientific article published in December 2016
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer
scientific article
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study
scientific article published on 17 December 2014
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk
scientific article
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
scientific article published on 27 August 2015
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology
scientific article published on 21 August 2018
Lists 0
Join to rate
Wikipedia

Adekunle O. Odunsi is an American gynecologic oncologist. In 2021, Odunsi became the director of the University of Chicago Comprehensive Cancer Center.

Instance of
Human
Occupation
Researcher
References
Wikidata